| 000 | 00931 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250518045740.0 | ||
| 264 | 0 | _c20200615 | |
| 008 | 202006s 0 0 eng d | ||
| 022 | _a1474-5488 | ||
| 024 | 7 |
_a10.1016/S1470-2045(19)30390-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHofheinz, Ralf-Dieter | |
| 245 | 0 | 0 |
_aStudy evidence confirms current clinical practice in refractory metastatic colorectal cancer: the ReDOS trial. _h[electronic resource] |
| 260 |
_bThe Lancet. Oncology _c08 2019 |
||
| 300 |
_a1036-1037 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Comment | ||
| 650 | 0 | 4 | _aColorectal Neoplasms |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aPhenylurea Compounds |
| 650 | 0 | 4 | _aPyridines |
| 700 | 1 | _aStintzing, Sebastian | |
| 773 | 0 |
_tThe Lancet. Oncology _gvol. 20 _gno. 8 _gp. 1036-1037 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S1470-2045(19)30390-0 _zAvailable from publisher's website |
| 999 |
_c29859019 _d29859019 |
||